Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with Glioblastoma and other cancers, announced that its prior and upcoming GBM immunotherapy clinical studies and preclinical studies will be presented as e-posters at the upcoming American Association for Cancer Research Virtual Annual Meeting 2021, April 10-15 and May 17-21.
March 3, 2021
· 2 min read